Diagnostics & Research
The Diagnostics & Research industry has a total of 48 stocks, with a combined market cap of $679.43 billion, total revenue of $169.45 billion and a weighted average PE ratio of 38.98.
Market Cap
679.43B
Revenue
169.45B
Profits
17.43B
PE Ratio
38.98
Profit Margin
10.29%
Dividend Yield
0.24%
48 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 176.13B | -1.69% | 1,496,883 | 45.20B |
| 2 | DHR | Danaher Corporation | 126.04B | 1.12% | 2,883,468 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.23B | 1.80% | 882,532 | 4.45B |
| 4 | A | Agilent Technologies, Inc. | 38.81B | 1.74% | 2,900,581 | 7.23B |
| 5 | WAT | Waters Corporation | 37.29B | 2.11% | 745,533 | 3.77B |
| 6 | IQV | IQVIA Holdings Inc. | 30.38B | 0.78% | 1,271,484 | 16.63B |
| 7 | NTRA | Natera, Inc. | 30.34B | -0.41% | 1,459,239 | 2.50B |
| 8 | ILMN | Illumina, Inc. | 25.92B | 5.38% | 3,116,777 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 23.63B | -0.06% | 185,461 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.44B | 0.26% | 420,209 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 21.23B | 0.47% | 489,577 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 16.84B | -2.41% | 2,111,120 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 12.89B | 1.27% | 239,024 | 2.68B |
| 14 | RVTY | Revvity, Inc. | 11.28B | 0.68% | 943,120 | 2.90B |
| 15 | ICLR | ICON Public Limited Company | 11.02B | 4.66% | 1,229,235 | 8.25B |
| 16 | CRL | Charles River Laboratories International, Inc. | 8.66B | 2.91% | 442,911 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 7.54B | 2.13% | 3,231,700 | 2.10B |
| 18 | BLLN | BillionToOne, Inc. | 4.53B | 4.44% | 976,860 | 354.54M |
| 19 | TWST | Twist Bioscience Corporation | 4.50B | 3.11% | 1,119,699 | 409.48M |
| 20 | SHC | Sotera Health Company | 4.35B | 1.63% | 2,480,289 | 1.19B |
| 21 | RDNT | RadNet, Inc. | 4.08B | -4.49% | 636,799 | 2.14B |
| 22 | VCYT | Veracyte, Inc. | 3.89B | 1.87% | 1,451,570 | 541.74M |
| 23 | GRAL | GRAIL, Inc. | 2.62B | 2.05% | 690,674 | 156.12M |
| 24 | ADPT | Adaptive Biotechnologies Corporation | 2.56B | 5.61% | 2,232,389 | 295.41M |
| 25 | WGS | GeneDx Holdings Corp. | 1.58B | -0.08% | 1,078,387 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.32B | 0.20% | 1,046,955 | 745.97M |
| 27 | CDNA | CareDx, Inc. | 1.15B | 1.09% | 551,310 | 412.82M |
| 28 | PSNL | Personalis, Inc. | 1.13B | -3.23% | 2,902,200 | 64.52M |
| 29 | OPK | OPKO Health, Inc. | 1.10B | 4.29% | 4,059,575 | 581.12M |
| 30 | CSTL | Castle Biosciences, Inc. | 618.12M | 3.40% | 443,017 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 515.76M | -2.89% | 624,302 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 415.57M | 2.09% | 1,739,358 | 829.00M |
| 33 | PRE | Prenetics Global Limited | 350.54M | -0.67% | 232,800 | 92.39M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 194.70M | 1.34% | 234,996 | 1.95M |
| 35 | BDSX | Biodesix, Inc. | 161.43M | 3.43% | 18,990 | 96.10M |
| 36 | FONR | FONAR Corporation | 125.07M | - | - | 105.34M |
| 37 | XGN | Exagen Inc. | 109.69M | -5.81% | 277,643 | 68.38M |
| 38 | BNR | Burning Rock Biotech Limited | 91.65M | -9.85% | 28,174 | 77.14M |
| 39 | PRPO | Precipio, Inc. | 42.91M | 6.94% | 61,023 | 25.83M |
| 40 | MDXH | MDxHealth SA | 30.99M | -5.90% | 875,210 | 110.97M |
| 41 | QUCY | Quantum Cyber N.V. | 30.79M | 0.41% | 3,153,348 | 537.08K |
| 42 | MBAI | Check-Cap Ltd. | 11.22M | -7.78% | 96,452 | - |
| 43 | XWEL | XWELL, Inc. | 11.10M | -4.71% | 94,559 | 28.83M |
| 44 | ADVB | Advanced Biomed Inc. | 7.80M | 6.94% | 8,201 | - |
| 45 | BIAF | bioAffinity Technologies, Inc. | 7.75M | 1.79% | 118,377 | 5.66M |
| 46 | NDRA | ENDRA Life Sciences Inc. | 6.19M | -0.99% | 12,512 | - |
| 47 | ISPC | iSpecimen Inc. | 4.31M | -2.28% | 124,896 | 1.03M |
| 48 | NOTV | Inotiv, Inc. | 4.18M | -53.96% | 22,016,324 | 507.36M |